文献速递妇产影像US

单绒毛膜双羊膜囊双胎妊娠合并选择性胎儿生长受限及脐动脉舒张末期血流持续或间歇性缺失或反向的国际多中心队列研究结局

Outcome of monochorionic diamniotic twin pregnancy with selective fetal growth restriction and continuous or intermittent absent or reversed end-diastolic umbilical artery flow: international multicenter cohort study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-05-29

这项国际回顾性队列研究纳入5个胎儿医学中心2016-2022年363例单绒毛膜双羊膜囊双胎合并选择性胎儿生长受限(脐动脉舒张末期血流持续或间歇性缺失或反向)病例,评估胎儿及新生儿结局,并比较选择性减胎与期待处理后大胎结局。结果显示小胎尤其持续血流异常者不良结局风险高,选择性减胎与大胎≥32周活产概率较高相关。

要点

  • 脐动脉血流模式在59%的妊娠中发生变化,最终超声评估至关重要。
  • 小胎持续舒张末期血流缺失或反向者存活率70%,存活者严重新生儿病率29%。
  • 37例自然胎死宫内中24例(65%)为双胎死亡,单胎死亡后存活者严重脑损伤约30%。

核心结论

  • 合并选择性胎儿生长受限及脐动脉舒张末期血流持续或间歇性缺失或反向的单绒毛膜双羊膜囊双胎妊娠胎儿死亡和严重病率风险高,尤其小胎伴持续血流异常者;与期待处理相比,选择性减胎显著提高大胎≥32周活产且无严重病率的机会,可能受出生孕周增加影响。

研究设计与样本

  • 国际回顾性队列研究,纳入5个胎儿医学中心2016-2022年共7年的363例单绒毛膜双羊膜囊双胎妊娠(726胎儿),以估计胎儿体重差异≥20%合并脐动脉舒张末期血流持续或间歇性缺失或反向为纳入标准。

诊断标准与关键数值

  • 纳入标准为估计胎儿体重差异≥20%合并脐动脉舒张末期血流持续或间歇性缺失或反向。
  • 最终超声评估时小胎伴持续血流异常者存活率70%,存活者严重新生儿病率29%;大胎存活率87%,存活者严重新生儿病率26%。
  • 最终超声评估时小胎伴间歇性血流异常者存活率83%,存活者严重新生儿病率22%;大胎存活率87%,存活者严重新生儿病率13%。
  • 小胎伴持续血流异常者不良结局(胎儿或新生儿死亡或严重新生儿病率)合计风险52%,伴间歇性血流异常者为37%。

临床应用与阅片要点

  • 选择性减胎与大胎≥32周活产概率较期待处理高32-34%相关,该获益似乎与出生孕周较晚和严重新生儿病率降低一致,尽管活产率相似。
  • 这些数据应有助于患者咨询和管理决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Monochorionic diamniotic (MCDA) twins with selective fetal growth restriction (sFGR) and either continuous (cAREDF) or intermittent (iAREDF) absent or reversed end-diastolic flow in the umbilical artery face significant fetal and neonatal risks. This study evaluated fetal and neonatal outcomes in these cases and compared outcomes for the larger twin following selective reduction (SR) vs expectant management (EM).

METHODS: This was an international retrospective cohort study of MCDA twin pregnancies with sFGR and cAREDF or iAREDF from five fetal medicine centers over 7 years (2016-2022). Patients were included based on an estimated fetal weight (EFW) discordance of ≥ 20% combined with cAREDF or iAREDF. We collected demographic and antenatal characteristics, longitudinal ultrasound and management data, and key perinatal outcomes, including gestational age (GA) at birth, survival rate and severe neonatal morbidity. Outcomes for the larger twin following SR vs EM were compared using logistic regression with standardization, inverse probability weighting and augmented inverse probability weighting to adjust for confounders. Average treatment effects (risk differences) were calculated for three composite outcomes (live birth at ≥ 32 weeks; live birth at ≥ 32 weeks and absence of severe neonatal morbidity; and live birth without a GA limit and absence of severe neonatal morbidity) and overall live birth.

RESULTS: Data were analyzed from 363 MCDA twin pregnancies (726 fetuses) with sFGR, which were diagnosed initially as having either cAREDF (n = 124) or iAREDF (n = 239). The umbilical artery flow pattern changed in 59% of pregnancies during gestation. Smaller twins with cAREDF at the final ultrasound scan before demise, delivery or intervention had a 70% survival rate, with 29% of survivors experiencing severe neonatal morbidity. In contrast, larger twins in this group had an 87% survival rate and a 26% risk of severe neonatal morbidity among survivors. For smaller twins with iAREDF at the final ultrasound scan, the survival rate was 83% and 22% of survivors were affected by severe neonatal morbidity, whereas larger twins had an 87% survival rate and a 13% risk of severe neonatal morbidity among survivors. The combined risk of adverse outcomes (fetal or neonatal demise or severe neonatal morbidity) was 52% for smaller twins with cAREDF and 37% for those with iAREDF. Among 37 cases of spontaneous fetal demise, 24 (65%) were double demise. Severe cerebral injury following single fetal demise occurred in approximately 30% of survivors. SR was associated with a 32-34% higher probability of the larger twin being liveborn ≥ 32 weeks compared with EM. This benefit seemed to align with later GA at birth and reduced rate of severe neonatal morbidity, despite similar rates of live birth.

CONCLUSIONS: MCDA twins with sFGR and cAREDF or iAREDF are at high risk for demise and severe morbidity, particularly the smaller twin with cAREDF. Compared with EM, SR significantly improves the chance of the larger twin being born at ≥ 32 weeks and surviving without severe morbidity, which may be influenced by increased GA at birth. These data should inform patient counseling and management decisions. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Noll ATR, van Hoogstraten A, Nulens K, et al. Outcome of monochorionic diamniotic twin pregnancy with selective fetal growth restriction and continuous or intermittent absent or reversed end-diastolic umbilical artery flow: international multicenter cohort study. Ultrasound Obstet Gynecol. 2025. PMID: 40443107. doi:10.1002/uog.29241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。